← Evidence map

ReviewAntibody therapeutics2020

Perspectives on the development of neutralizing antibodies against SARS-CoV-2.

Mitchell HoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

33 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32566896